We evaluated the effects of sequential therapy with caspofungin (CAS) or amphotericin B (AMB) followed by posaconazole (POS) against Candida glabrata. The susceptibilities to POS of yeast cells pre-exposed to CAS or AMB were identical to those of untreated cells as shown by standard Clinical and Laboratory Standards Institute broth dilution, cell viability, and disk diffusion methods. We then investigated the activity of sequential regimens in an experimental model of disseminated candidiasis. CAS given at 1 mg/kg/day for 2 days followed by POS at either 15 or 30 mg/kg/day significantly reduced the counts compared to the controls, but this treatment was not superior to the use of CAS alone. Also, sequential regimens with AMB given at 1 mg/kg/day for 2 days followed by POS (AMB/POS) were effective at reducing the fungal burden against the controls. In addition, AMB/POS with both doses of the triazole were significantly more effective than AMB alone. Overall, our data showed that there is no therapeutic advantage in using CAS followed by POS, whereas an induction therapy with AMB followed by a maintenance regimen with POS might be a suitable strategy in managing C. glabrata infections.

SPREGHINI E, MAIDA CM, MILICI ME, & SCALISE G AND BARCHIESI F (2008). Posaconazole Activity against Candida glabrata after Exposure to Caspofungin or Amfotericin B. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 52(2), 513-517 [10.1128/AAC.01447-07].

Posaconazole Activity against Candida glabrata after Exposure to Caspofungin or Amfotericin B.

MAIDA, Carmelo Massimo;MILICI, Maria Eleonora;
2008

Abstract

We evaluated the effects of sequential therapy with caspofungin (CAS) or amphotericin B (AMB) followed by posaconazole (POS) against Candida glabrata. The susceptibilities to POS of yeast cells pre-exposed to CAS or AMB were identical to those of untreated cells as shown by standard Clinical and Laboratory Standards Institute broth dilution, cell viability, and disk diffusion methods. We then investigated the activity of sequential regimens in an experimental model of disseminated candidiasis. CAS given at 1 mg/kg/day for 2 days followed by POS at either 15 or 30 mg/kg/day significantly reduced the counts compared to the controls, but this treatment was not superior to the use of CAS alone. Also, sequential regimens with AMB given at 1 mg/kg/day for 2 days followed by POS (AMB/POS) were effective at reducing the fungal burden against the controls. In addition, AMB/POS with both doses of the triazole were significantly more effective than AMB alone. Overall, our data showed that there is no therapeutic advantage in using CAS followed by POS, whereas an induction therapy with AMB followed by a maintenance regimen with POS might be a suitable strategy in managing C. glabrata infections.
Settore MED/07 - Microbiologia E Microbiologia Clinica
SPREGHINI E, MAIDA CM, MILICI ME, & SCALISE G AND BARCHIESI F (2008). Posaconazole Activity against Candida glabrata after Exposure to Caspofungin or Amfotericin B. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 52(2), 513-517 [10.1128/AAC.01447-07].
File in questo prodotto:
File Dimensione Formato  
2007 - POSACONAZOLE ACTIVITY AMB.pdf

accesso aperto

Descrizione: Articolo principale
Dimensione 123.22 kB
Formato Adobe PDF
123.22 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10447/38152
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact